Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine
- PMID: 33687691
- PMCID: PMC7940863
- DOI: 10.1007/s11739-021-02685-0
Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine
Keywords: Adverse effects; COVID-19 vaccines; Deep vein thrombosis; MRNA vaccine.
Conflict of interest statement
The authors state that they have no relevant conflict of interest to disclose.
Comment in
-
COVID-19 vaccines and thrombosis.Intern Emerg Med. 2022 Mar;17(2):587-588. doi: 10.1007/s11739-021-02823-8. Epub 2021 Oct 12. Intern Emerg Med. 2022. PMID: 34637083 Free PMC article. No abstract available.
References
-
- European Medicines Agency (2021) Treatments and vaccines for COVID-19: authorised medicines. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-thr.... Accessed 15 Feb 2021
-
- Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. doi: 10.1016/S0140-6736(20)32661-1. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous